Tenley Archer
Affiliations: | 2020- | Algen Biotechnologies |
Google:
"Tenley Archer"Mean distance: 15.51 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorElena S. Casey | grad student | Georgetown | |
Scott L. Pomeroy | post-doc | 2011- | Harvard Medical School/Children's Hospital |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Maynard R, Poore B, Hanaford AR, et al. (2021) TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters |
Archer TC, Ehrenberger T, Mundt F, et al. (2018) Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8 |
Waszak SM, Northcott PA, Buchhalter I, et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology |
Archer TC, Sengupta S, Pomeroy SL. (2018) Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797 |
Archer TC, Mahoney EL, Pomeroy SL. (2017) Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
Boulay G, Awad ME, Riggi N, et al. (2017) OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery |
Wang X, Lee RS, Alver BH, et al. (2016) SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics |
Hanaford AR, Archer TC, Price A, et al. (2016) DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Hanaford A, Archer T, Price A, et al. (2016) MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS Neuro-Oncology. 18: iii120.3-iii120 |
Archer TC, Pomeroy SL. (2015) Defining the molecular landscape of ependymomas. Cancer Cell. 27: 613-5 |